N

Nanobiotix SA
D

NBTX

3.75700
USD
-0.19
(-4.89%)
مغلق
حجم التداول
242
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
178,099,582
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABCL
    -0.10500
    (-3.34%)
    3.04000 USD
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    ADPT
    -0.06500
    (-0.78%)
    8.27000 USD
    A
    ALLO
    -0.07500
    (-3.33%)
    2.17500 USD
    A
    APLS
    -0.850
    (-3.00%)
    27.510 USD
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    I
    IMVT
    0.800
    (3.92%)
    21.230 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    المزيد
الأخبار
المقالات

العنوان: Nanobiotix SA

القطاع: Healthcare
الصناعة: Biotechnology
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.